A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News What J&J’s ortho spinoff means for the industryHealthradar16. Oktober 2025 Johnson & Johnson’s plan to spin out its orthopedics segment could give the business a chance to become a stronger…
